Cardiovascular events · people with CKD
Uric acid lowering therapies (UAR) showed no clear difference in cardiovascular events compared with placebo, no treatment or usual care (low certainty).
1 finding from 1 review
Cure: number of women with self‐reported continence · women with stress urinary incontinence
It is very uncertain whether electrical stimulation plus surgery changes cure: number of women with self‐reported continence compared with surgery (very low certainty).
1 finding from 1 review
Improvement: number of women with self‐reported improvement in SUI (cured or improved) · women with stress urinary incontinence
It is very uncertain whether electrical stimulation plus surgery changes improvement: number of women with self‐reported improvement in SUI… compared with surgery (very low certainty).
1 finding from 1 review
Incontinence‐specific quality of life · women with stress urinary incontinence
1 finding from 1 review
Adverse effects · women with stress urinary incontinence
It is very uncertain whether electrical stimulation plus surgery changes adverse effects compared with surgery (very low certainty).
1 finding from 1 review
Cost‐effectiveness · women with stress urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · patients with patellofemoral pain syndrome (symptoms > 4 weeks (1 study); symptoms > 6 weeks (1 study); symptoms > 8 weeks (1 study); not…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Knee pain (short term) VAS scale: 0 to 10; higher score = worse pain. · patients with patellofemoral pain syndrome (symptoms > 4 weeks (1 study); symptoms > 6 weeks (1 study); symptoms > 8 weeks (1 study); not…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Knee pain (longer term: > 3 months) · patients with patellofemoral pain syndrome (symptoms > 4 weeks (1 study); symptoms > 6 weeks (1 study); symptoms > 8 weeks (1 study); not…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Knee function (short term) · patients with patellofemoral pain syndrome (symptoms > 4 weeks (1 study); symptoms > 6 weeks (1 study); symptoms > 8 weeks (1 study); not…
It is very uncertain whether neuromuscular electrical stimulation changes knee function (short term) Arpège function scale (0 to 18; higher… compared with exercise (very low certainty).
1 finding from 1 review
Knee function (longer term: > 3 months) · patients with patellofemoral pain syndrome (symptoms > 4 weeks (1 study); symptoms > 6 weeks (1 study); symptoms > 8 weeks (1 study); not…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Major complications · adults receiving intravenous fluids while undergoing major non‐cardiac surgery
It is very uncertain whether perioperative restrictive fluid therapy changes major complications (during longest compared with goal‐directed fluid therapy (very low certainty).
1 finding from 1 review
Mortality within the longest · adults receiving intravenous fluids while undergoing major non‐cardiac surgery
It is very uncertain whether perioperative restrictive fluid therapy changes all‐cause mortality (during longest compared with goal‐directed fluid therapy (very low certainty).
1 finding from 1 review
Length of hospital stay · adults receiving intravenous fluids while undergoing major non‐cardiac surgery
It is very uncertain whether perioperative restrictive fluid therapy changes length of hospital stay (days) compared with goal‐directed fluid therapy (very low certainty).
1 finding from 1 review
Surgery‐related complications (during longest · adults receiving intravenous fluids while undergoing major non‐cardiac surgery
It is very uncertain whether perioperative restrictive fluid therapy changes surgery‐related complications (during longest compared with goal‐directed fluid therapy (very low certainty).
1 finding from 1 review
Non‐surgery‐related complications (during longest · adults receiving intravenous fluids while undergoing major non‐cardiac surgery
It is very uncertain whether perioperative restrictive fluid therapy changes non‐surgery‐related complications (during longest compared with goal‐directed fluid therapy (very low certainty).
1 finding from 1 review
Renal failure · adults receiving intravenous fluids while undergoing major non‐cardiac surgery
It is very uncertain whether perioperative restrictive fluid therapy changes renal failure (during longest compared with goal‐directed fluid therapy (very low certainty).
1 finding from 1 review
Quality of surgical recovery assessed in any way (e.g. as a surgical recovery score) (during longest · adults receiving intravenous fluids while undergoing major non‐cardiac surgery
1 finding from 1 review
Participants cured or improved · Adults with overactive bladder (OAB)
1 finding from 1 review
Participants with improvement in urgency urinary incontinence · Adults with overactive bladder (OAB)
1 finding from 1 review